Communicating cancer is complicated. Among other things, because it’s really hard to unveil interesting research results without over-hyping and sparkling unrealistic hope. That’s why we’re especially proud of our collaboration with the EPSRC Interdisciplinary Research Collaboration (IRC) for hard-to-treat cancers, led by the University of Cambridge. They’re making enormous advances that could benefit millions of people—and we got to add our personal touch to that.